We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-3.35%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$5.2B
AUM Growth
+$223M
Cap. Flow
+$501M
Cap. Flow %
9.63%
Top 10 Hldgs %
30.56%
Holding
1,228
New
36
Increased
827
Reduced
326
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$30.8M
2
MSFT icon
Microsoft
MSFT
+$27.5M
3
AMZN icon
Amazon
AMZN
+$16.1M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$12.9M
5
TSLA icon
Tesla
TSLA
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 28.52%
2 Healthcare 13.99%
3 Consumer Discretionary 13.11%
4 Financials 11.18%
5 Industrials 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRO
351
DELISTED
Marathon Oil Corporation
MRO
$2.32M 0.04%
102,617
+12,763
+14% +$302K
TER icon
352
Teradyne
TER
$56B
$2.3M 0.04%
30,641
+1,730
+6% +$158K
ABMD
353
DELISTED
Abiomed Inc
ABMD
$2.3M 0.04%
9,359
+642
+7% +$173K
FITB
354
Fifth Third Bancorp
FITB
$49.5B
$2.29M 0.04%
71,737
-47,485
-40% -$1.64M
BALL icon
355
Ball Corp
BALL
$16.8B
$2.29M 0.04%
47,323
+5,539
+13% +$341K
PTC icon
356
PTC
PTC
$17.1B
$2.29M 0.04%
21,866
+1,505
+7% +$172K
GNRC icon
357
Generac Holdings
GNRC
$10.9B
$2.28M 0.04%
12,824
+1,032
+9% +$237K
IRM icon
358
Iron Mountain
IRM
$35.3B
$2.27M 0.04%
51,733
+4,357
+9% +$220K
AVY icon
359
Avery Dennison
AVY
$13.4B
$2.27M 0.04%
13,961
+1,061
+8% +$192K
HBAN icon
360
Huntington Bancshares
HBAN
$34.1B
$2.27M 0.04%
171,901
+10,470
+6% +$140K
WTW icon
361
Willis Towers Watson
WTW
$32B
$2.26M 0.04%
11,261
+1,592
+16% +$329K
TECH icon
362
Bio-Techne
TECH
$11.4B
$2.26M 0.04%
31,832
+2,092
+7% +$181K
DTE icon
363
DTE Energy
DTE
$28.3B
$2.26M 0.04%
19,612
+3,104
+19% +$401K
ZBH icon
364
Zimmer Biomet
ZBH
$19.1B
$2.25M 0.04%
21,514
+3,537
+20% +$388K
HII icon
365
Huntington Ingalls Industries
HII
$11.5B
$2.24M 0.04%
10,121
+540
+6% +$121K
FICO icon
366
Fair Isaac
FICO
$25B
$2.23M 0.04%
5,420
-185
-3% -$84K
NBIX icon
367
Neurocrine Biosciences
NBIX
$15.7B
$2.22M 0.04%
20,922
+57
+0.3% +$5.78K
SGEN
368
DELISTED
Seagen Inc. Common Stock
SGEN
$2.2M 0.04%
16,101
+162
+1% +$26.4K
HIG icon
369
Hartford Financial Services
HIG
$37.5B
$2.2M 0.04%
35,518
+6,137
+21% +$399K
MLM icon
370
Martin Marietta Materials
MLM
$37.5B
$2.19M 0.04%
6,807
+887
+15% +$300K
EIX icon
371
Edison International
EIX
$27.8B
$2.19M 0.04%
38,615
+6,390
+20% +$423K
WY icon
372
Weyerhaeuser
WY
$17B
$2.17M 0.04%
76,164
-11,959
-14% -$407K
NVR icon
373
NVR
NVR
$16.9B
$2.16M 0.04%
542
+42
+8% +$179K
ARE icon
374
Alexandria Real Estate Equities
ARE
$8.95B
$2.16M 0.04%
15,397
+2,322
+18% +$356K
CRL icon
375
Charles River Laboratories
CRL
$14B
$2.13M 0.04%
10,796
+1,021
+10% +$220K

Similar funds

Xponance's Q3 2022 Portfolio in Review

As of Q3 2022, Xponance held 1,228 positions worth $5.2B, up 4.5% from $4.98B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Xponance deployed $501M of net new capital in Q3 2022, opening 36 new positions and adding to 827 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 27,780 shares worth $1.22M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinnacle West Capital, an estimated $2.46M trimmed.

  • Xponance's largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 27,780 shares worth $1.22M.
  • Xponance added most to Apple in Q3 2022, an estimated $30.8M increase.
  • Xponance's biggest Q3 2022 reduction was Pinnacle West Capital, cutting an estimated $2.46M.
  • Xponance fully exited Atlassian in Q3 2022, selling an estimated $2.99M.
  • Xponance's ten largest holdings make up 31% of its $5.2B portfolio in Q3 2022.
  • Xponance opened 36 new positions and closed 36 in Q3 2022.
  • Xponance's portfolio value rose 4.5% quarter-over-quarter to $5.2B.

Based on Xponance's 13F filing for Q3 2022, filed 24 Oct 2022.